Iain J. Webb

6.1k total citations · 1 hit paper
56 papers, 4.5k citations indexed

About

Iain J. Webb is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Iain J. Webb has authored 56 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 24 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Iain J. Webb's work include Prostate Cancer Treatment and Research (19 papers), Multiple Myeloma Research and Treatments (15 papers) and Radiopharmaceutical Chemistry and Applications (14 papers). Iain J. Webb is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Multiple Myeloma Research and Treatments (15 papers) and Radiopharmaceutical Chemistry and Applications (14 papers). Iain J. Webb collaborates with scholars based in United States, Canada and France. Iain J. Webb's co-authors include Alessandro Aiuti, José Carlos Gutierrez‐Ramos, Conrad C. Bleul, Timothy A. Springer, Kenneth C. Anderson, Gary S. Gray, Karen Gray, Jeffrey S. Ross, Hugh A.�G. Fisher and Prabhjot Kaur and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Iain J. Webb

52 papers receiving 4.4k citations

Hit Papers

The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ ... 1997 2026 2006 2016 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
    1997 1.2k citations Iain J. Webb et al. profile →

Peers

Iain J. Webb
Kiyohiko Hatake Japan
John P. Chute United States
Antonio Pinto Italy
Hartmut Kirchner Germany
Martin Gramatzki Germany
Leonhard Müllauer Austria
Ulrich Jäger Austria
Lawrence G. Lum United States
Girolamo Ranieri Italy
Robert Vescio United States
Kiyohiko Hatake Japan
Iain J. Webb
Citations per year, relative to Iain J. Webb Iain J. Webb (= 1×) peers Kiyohiko Hatake

Countries citing papers authored by Iain J. Webb

Since Specialization
Citations

This map shows the geographic impact of Iain J. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain J. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain J. Webb more than expected).

Fields of papers citing papers by Iain J. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iain J. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain J. Webb. The network helps show where Iain J. Webb may publish in the future.

Co-authorship network of co-authors of Iain J. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Iain J. Webb. A scholar is included among the top collaborators of Iain J. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iain J. Webb. Iain J. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dietrich, Thomas, Iain J. Webb, Derren Ready, et al.. (2017). Evidence summary: the relationship between oral and cardiovascular disease. BDJ. 222(5). 381–385. 116 indexed citations
3.
Heller, Glenn, Karim Fizazi, Robert G. McCormack, et al.. (2016). The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population. Clinical Cancer Research. 23(8). 1967–1973. 43 indexed citations
4.
5.
Dreicer, Robert, David B. MacLean, Ajit Suri, et al.. (2014). Phase I/II Trial of Orteronel (TAK-700)—an Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 20(5). 1335–1344. 34 indexed citations
6.
Sartor, Oliver, Emuella Flood, Kathleen Beusterien, et al.. (2014). Health-Related Quality of Life in Advanced Prostate Cancer and Its Treatments: Biochemical Failure and Metastatic Disease Populations. Clinical Genitourinary Cancer. 13(2). 101–112. 28 indexed citations
7.
Kumar, Shaji, Ian W. Flinn, Paul G. Richardson, et al.. (2012). Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. Blood. 119(19). 4375–4382. 318 indexed citations
8.
Kumar, Shaji, Ian W. Flinn, Stephen J. Noga, et al.. (2010). Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study. Leukemia. 24(7). 1350–1356. 60 indexed citations
9.
Flinn, Ian W., J. Wolf, Cristina Gasparetto, et al.. (2009). A247 Bortezomib, Dexamethasone, Cyclophosphamide, Lenalidomide (VDCR) Has High Efficacy in First-Line MM. Clinical Lymphoma & Myeloma. 9. S43–S44.
10.
Dreicer, Robert, Daniel P. Petrylak, David B. Agus, Iain J. Webb, & Bruce J. Roth. (2007). Phase I/II Study of Bortezomib Plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer. Clinical Cancer Research. 13(4). 1208–1215. 58 indexed citations
11.
Milowsky, Mathew I., Matthew D. Galsky, Daniel J. George, et al.. (2006). Phase I/II trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients (pts) with progressive metastatic castration resistant prostate cancer (CRPC). Journal of Clinical Oncology. 24(18_suppl). 4500–4500. 12 indexed citations
12.
Ross, Jeffrey S., Karen Gray, Iain J. Webb, et al.. (2005). Antibody-based therapeutics: Focus on prostate cancer. Cancer and Metastasis Reviews. 24(4). 521–537. 31 indexed citations
13.
Galsky, Matthew D., Mario Eisenberger, William K. Kelly, et al.. (2004). Phase I trial of MLN2704 in patients with castrate-metastatic prostate cancer (CMPC). Journal of Clinical Oncology. 22(14_suppl). 4592–4592. 2 indexed citations
14.
Webb, Iain J., Jonathan W. Friedberg, John G. Gribben, et al.. (2002). Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 8(8). 429–434. 7 indexed citations
15.
Webb, Iain J., et al.. (1998). Sequential CD34+ and CD4+ Cell Selection from Leukapheresis Components. Journal of Hematotherapy. 7(2). 169–174.
16.
Teoh, Gerrard, Ling Chen, Mitsuyoshi Urashima, et al.. (1998). Adenovirus Vector-Based Purging of Multiple Myeloma Cells. Blood. 92(12). 4591–4601. 17 indexed citations
17.
Shapiro, Charles L., Lois Ayash, Iain J. Webb, et al.. (1997). Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.. Journal of Clinical Oncology. 15(2). 674–683. 24 indexed citations
18.
19.
Webb, Iain J., F Coral, J. W. Andersen, et al.. (1996). Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion. 36(9). 782–788. 64 indexed citations
20.
Webb, Iain J., et al.. (1988). Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Experimental Cell Research. 176(1). 87–95. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by John P. Chute Breakdown of academic impact, for papers by Antonio Pinto Breakdown of academic impact, for papers by Hartmut Kirchner Breakdown of academic impact, for papers by Martin Gramatzki Breakdown of academic impact, for papers by Leonhard Müllauer Breakdown of academic impact, for papers by Ulrich Jäger Breakdown of academic impact, for papers by Lawrence G. Lum Breakdown of academic impact, for papers by Girolamo Ranieri Breakdown of academic impact, for papers by Robert Vescio
Rankless by CCL
2026